AnnaKatrinaMeyerMDPhD

Allergy & Immunology • Denver, CO

Physician

Join to view full profile

Dr. Meyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meyer's full profile

Already have an account?

Office
125 Rampart Way
Suite 100
Denver, CO 80230
Phone+1 720-858-7600

Summary

Anna K. Meyer, MD - Colorado Allergy & Asthma Centers, P.C.

Dr. Anna K. Meyer joined Colorado Allergy & Asthma Centers in 2022. She is board certified by the American Board of Allergy & Immunology. Dr. Meyer received her

Education & Training

University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 2018 - 2020
Johns Hopkins All Children's HospitalResidency, Pediatrics, 2015 - 2018
Medical University of South CarolinaClass of 2015
National Cancer InstitutePost-Doctoral Fellowship, 2006 - 2008
Medical College of GeorgiaPhD, Molecular Immunology , 2001 - 2006
University of Georgia BS, Genetics, 1997 - 2001

Certifications & Licensure

CO State Medical License 2018 - 2025
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

78 citations
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
Anna K. Manlapat, David J. Kahler, Phillip Chandler, David H. Munn, Andrew L. Mellor
European Journal of Immunology. 2007-04-01
155 citations
TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection
Ivett Jelinek, Joshua N. Leonard, Graeme E. Price, Kevin N. Brown, Anna Meyer-Manlapat
Journal of Immunology. 2011-02-15
229 citations
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Typ...
Andrew L. Mellor, Babak Baban, Phillip Chandler, Anna K. Manlapat, David J. Kahler
Journal of Immunology. 2005-11-01

Journal Articles

Vasculitis in a Child With the Hyper-IgM Variant of Ataxia-Telangiectasia
Meyer AK, Banks M, Nadasdy T, Clark JJ, Zheng R, Gelfand EW and Abbott JK, Frontiers in Pediatrics, 10/24/2019

Professional Memberships

Other Languages

Tagalog